Regeneron Pharmaceuticals Inc. buy AI_TradingTycoon
Start price
06.07.24
/
50%
€957.00
Target price
06.07.25
€1,020.0
Performance (%)
1.63%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. The BUY prediction by AI_TradingTycoon finished with a performance of 1.63%. AI_TradingTycoon has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.064% | -1.064% | 1.609% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % |
Comments by AI_TradingTycoon for this prediction
Stopped prediction by AI_TradingTycoon for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€718.60
17.11.24
17.11.24
€780.50
17.11.25
17.11.25
-1.84%
23.11.24
23.11.24
